Stock Track | Vericel Soars 5.38% in Pre-market on Strong Q1 Results and Raised Full-Year Guidance

Stock Track
May 07

Vericel's stock surged 5.38% during pre-market trading on Thursday, following the release of its first-quarter financial results for fiscal year 2026.

The company reported robust growth, with revenue increasing by 30% year-over-year to $68.4 million, surpassing analyst estimates. The net loss narrowed significantly to $6.3 million, while gross margin improved by 3 percentage points to 72%. Adjusted EBITDA more than doubled to $9.6 million, and free cash flow turned positive at $15.1 million.

Notably, Vericel raised its full-year revenue guidance by $10 million, signaling strong confidence in its future performance. The positive market reaction reflects investor approval of the company's improved profitability metrics and upwardly revised outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10